Evan Soltas and Jonathan Gruber have published a paper titled, “How Costly Is Permitting in Housing Development?”. They ...
Kyverna is leading other companies in the CAR-T sector. Their flagship product is KYV-101. It takes cells from the patient and engineers them with CD28 stimulation. Kyverna’s KYSA-8 delivered data on ...
Energy Transfer remains strongly bullish, offering over 33% upside potential and robust distribution coverage amid sector tailwinds. Learn more about ET stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results